These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 29463808)

  • 21. MMCL-CDR: enhancing cancer drug response prediction with multi-omics and morphology images contrastive representation learning.
    Li Y; Guo Z; Gao X; Wang G
    Bioinformatics; 2023 Dec; 39(12):. PubMed ID: 38070154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dielectrophoretic analysis of treated cancer cells for rapid assessment of treatment efficacy.
    Mahabadi S; Labeed FH; Hughes MP
    Electrophoresis; 2018 Apr; 39(8):1104-1110. PubMed ID: 29405335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prediction of cancer drug sensitivity based on genomic feature distribution alignment and drug structure information].
    Lian L; Yang X
    Sheng Wu Gong Cheng Xue Bao; 2024 Jul; 40(7):2235-2245. PubMed ID: 39044587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrating Domain Specific Knowledge and Network Analysis to Predict Drug Sensitivity of Cancer Cell Lines.
    Kim S; Sundaresan V; Zhou L; Kahveci T
    PLoS One; 2016; 11(9):e0162173. PubMed ID: 27607242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improving prediction of phenotypic drug response on cancer cell lines using deep convolutional network.
    Liu P; Li H; Li S; Leung KS
    BMC Bioinformatics; 2019 Jul; 20(1):408. PubMed ID: 31357929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A link prediction approach to cancer drug sensitivity prediction.
    Turki T; Wei Z
    BMC Syst Biol; 2017 Oct; 11(Suppl 5):94. PubMed ID: 28984192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual-Layer Strengthened Collaborative Topic Regression Modeling for Predicting Drug Sensitivity.
    Wang H; Xi J; Wang M; Li A
    IEEE/ACM Trans Comput Biol Bioinform; 2020; 17(2):587-598. PubMed ID: 30106738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kernelized rank learning for personalized drug recommendation.
    He X; Folkman L; Borgwardt K
    Bioinformatics; 2018 Aug; 34(16):2808-2816. PubMed ID: 29528376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In silico drug combination discovery for personalized cancer therapy.
    Jeon M; Kim S; Park S; Lee H; Kang J
    BMC Syst Biol; 2018 Mar; 12(Suppl 2):16. PubMed ID: 29560824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meta-GDBP: a high-level stacked regression model to improve anticancer drug response prediction.
    Su R; Liu X; Xiao G; Wei L
    Brief Bioinform; 2020 May; 21(3):996-1005. PubMed ID: 30868164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A computational method for drug sensitivity prediction of cancer cell lines based on various molecular information.
    Ahmadi Moughari F; Eslahchi C
    PLoS One; 2021; 16(4):e0250620. PubMed ID: 33914775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DROEG: a method for cancer drug response prediction based on omics and essential genes integration.
    Wu P; Sun R; Fahira A; Chen Y; Jiangzhou H; Wang K; Yang Q; Dai Y; Pan D; Shi Y; Wang Z
    Brief Bioinform; 2023 Mar; 24(2):. PubMed ID: 36715269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TransCDR: a deep learning model for enhancing the generalizability of drug activity prediction through transfer learning and multimodal data fusion.
    Xia X; Zhu C; Zhong F; Liu L
    BMC Biol; 2024 Oct; 22(1):227. PubMed ID: 39385185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multi-task deep latent spaces for cancer survival and drug sensitivity prediction.
    Rintala TJ; Napolitano F; Fortino V
    Bioinformatics; 2024 Sep; 40(Suppl 2):ii182-ii189. PubMed ID: 39230696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Culture and Drug Profiling of Patient Derived Malignant Pleural Effusions for Personalized Cancer Medicine.
    Ruiz C; Kustermann S; Pietilae E; Vlajnic T; Baschiera B; Arabi L; Lorber T; Oeggerli M; Savic S; Obermann E; Singer T; Rothschild SI; Zippelius A; Roth AB; Bubendorf L
    PLoS One; 2016; 11(8):e0160807. PubMed ID: 27548442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. US cancer institute to overhaul tumour cell lines.
    Ledford H
    Nature; 2016 Feb; 530(7591):391. PubMed ID: 26911756
    [No Abstract]   [Full Text] [Related]  

  • 37. Drug Discovery Testing Compounds in Patient Samples by Automated Flow Cytometry.
    Hernández P; Gorrochategui J; Primo D; Robles A; Rojas JL; Espinosa AB; Gómez C; Martínez-López J; Bennett TA; Ballesteros J
    SLAS Technol; 2017 Jun; 22(3):325-337. PubMed ID: 28340541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 3D Culture as a Clinically Relevant Model for Personalized Medicine.
    Fong ELS; Toh TB; Yu H; Chow EK
    SLAS Technol; 2017 Jun; 22(3):245-253. PubMed ID: 28277923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In-silico drug screening and potential target identification for hepatocellular carcinoma using Support Vector Machines based on drug screening result.
    Yang WL; Lee YE; Chen MH; Chao KM; Huang CY
    Gene; 2013 Apr; 518(1):201-8. PubMed ID: 23220021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current Trends in Drug Sensitivity Prediction.
    Cortes-Ciriano I; Mervin LH; Bender A
    Curr Pharm Des; 2016; 22(46):6918-6927. PubMed ID: 27784247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.